
Chinese General Practice ›› 2022, Vol. 25 ›› Issue (17): 2115-2120.DOI: 10.12114/j.issn.1007-9572.2022.0005
Special Issue: 数智医疗最新文章合辑
• Article • Previous Articles Next Articles
Received:2021-12-21
Revised:2022-02-14
Published:2022-04-28
Online:2022-04-28
Contact:
Jingyu LIU
About author:
通讯作者:
刘敬禹
作者简介:基金资助:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2022.0005
| 项目 | 例数 | 年龄( | 性别〔n(%)〕 | 吸烟史〔n(%)〕 | 癌症家族史〔n(%)〕 | 结节单、多发〔n(%)〕 | 结节平均直径( | 结节体积( | 实性占比( | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 男 | 女 | 有 | 无 | 有 | 无 | 单发 | 多发 | ||||||
| 实性结节组 | 82 | 54.7±12.9 | 46(56.1) | 36(43.9) | 33(40.2) | 49(59.8) | 30(36.6) | 52(63.4) | 28(34.1) | 54(65.9) | 1.1±0.5 | 881.2±460.5 | 91.0±11.3 |
| GGN组 | 93 | 55.6±11.6 | 57(61.3) | 36(38.7) | 31(33.3) | 62(66.7) | 33(35.5) | 60(64.5) | 32(34.4) | 61(65.6) | 1.2±0.5 | 793.0±456.5 | 21.8±19.7 |
| 检验统计量值 | -0.496a | 0.485 | 0.897 | 0.120 | 0.001 | -0.327a | 1.271a | 28.360a | |||||
| P值 | 0.621 | 0.486 | 0.344 | 0.729 | 0.971 | 0.744 | 0.206 | <0.001 | |||||
| 项目 | 结节部位〔n(%)〕 | 恶性概率〔n(%)〕 | 表面征象〔n(%)〕 | 平均CT值( | 偏度〔M(P 25,P 75)〕 | 峰度( | |||||||
| 右肺上叶 | 右肺中叶 | 右肺下叶 | 左肺上叶 | 左肺下叶 | 中危 | 高危 | 有 | 无 | |||||
| 实性结节组 | 22(26.8) | 11(13.4) | 16(19.5) | 25(30.5) | 8(9.8) | 40(48.8) | 42(51.2) | 40(48.8) | 42(51.2) | -222.8±216.8 | 0.6(-0.1,1.4) | 2.3±0.7 | |
| GGN组 | 35(37.6) | 8(8.6) | 12(12.9) | 26(28.0) | 12(12.9) | 44(47.3) | 49(52.7) | 45(48.4) | 48(51.6) | -600.2±191.1 | 0.3(-0.1,1.1) | 2.3±0.8 | |
| 检验统计量值 | 4.155 | 0.038 | 0.003 | 12.239a | 1.285b | -0.639a | |||||||
| P值 | 0.385 | 0.846 | 0.959 | <0.001 | 0.201 | 0.524 | |||||||
Table 1 Comparison of clinical data and imaging findings between patients with solid and ground-glass pulmonary nodules
| 项目 | 例数 | 年龄( | 性别〔n(%)〕 | 吸烟史〔n(%)〕 | 癌症家族史〔n(%)〕 | 结节单、多发〔n(%)〕 | 结节平均直径( | 结节体积( | 实性占比( | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 男 | 女 | 有 | 无 | 有 | 无 | 单发 | 多发 | ||||||
| 实性结节组 | 82 | 54.7±12.9 | 46(56.1) | 36(43.9) | 33(40.2) | 49(59.8) | 30(36.6) | 52(63.4) | 28(34.1) | 54(65.9) | 1.1±0.5 | 881.2±460.5 | 91.0±11.3 |
| GGN组 | 93 | 55.6±11.6 | 57(61.3) | 36(38.7) | 31(33.3) | 62(66.7) | 33(35.5) | 60(64.5) | 32(34.4) | 61(65.6) | 1.2±0.5 | 793.0±456.5 | 21.8±19.7 |
| 检验统计量值 | -0.496a | 0.485 | 0.897 | 0.120 | 0.001 | -0.327a | 1.271a | 28.360a | |||||
| P值 | 0.621 | 0.486 | 0.344 | 0.729 | 0.971 | 0.744 | 0.206 | <0.001 | |||||
| 项目 | 结节部位〔n(%)〕 | 恶性概率〔n(%)〕 | 表面征象〔n(%)〕 | 平均CT值( | 偏度〔M(P 25,P 75)〕 | 峰度( | |||||||
| 右肺上叶 | 右肺中叶 | 右肺下叶 | 左肺上叶 | 左肺下叶 | 中危 | 高危 | 有 | 无 | |||||
| 实性结节组 | 22(26.8) | 11(13.4) | 16(19.5) | 25(30.5) | 8(9.8) | 40(48.8) | 42(51.2) | 40(48.8) | 42(51.2) | -222.8±216.8 | 0.6(-0.1,1.4) | 2.3±0.7 | |
| GGN组 | 35(37.6) | 8(8.6) | 12(12.9) | 26(28.0) | 12(12.9) | 44(47.3) | 49(52.7) | 45(48.4) | 48(51.6) | -600.2±191.1 | 0.3(-0.1,1.1) | 2.3±0.8 | |
| 检验统计量值 | 4.155 | 0.038 | 0.003 | 12.239a | 1.285b | -0.639a | |||||||
| P值 | 0.385 | 0.846 | 0.959 | <0.001 | 0.201 | 0.524 | |||||||
| 变量 | 赋值 |
|---|---|
| 肺结节增长 | 增长=1,无增长=0 |
| 年龄 | 实测值 |
| 性别 | 男=1,女=0 |
| 吸烟史 | 有=1,无=0 |
| 癌症家族史 | 有=1,无=0 |
| 结节类型 | 多发=1,单发=0 |
| 结节平均直径 | 实测值 |
| 结节体积 | 实测值 |
| 实性占比 | 实测值 |
| 结节部位 | 右肺上叶=1,右肺中叶=2,右肺下叶=3,左肺上叶=4,左肺下叶=5 |
| 恶性概率 | 高危=1,中危=0 |
| 表面征象 | 有=1,无=0 |
| 平均CT值 | 实测值 |
| 偏度 | 实测值 |
| 峰度 | 实测值 |
Table 2 Cox proportional risk regression analysis variable assignment table of influencing factors of pulmonary nodule growth
| 变量 | 赋值 |
|---|---|
| 肺结节增长 | 增长=1,无增长=0 |
| 年龄 | 实测值 |
| 性别 | 男=1,女=0 |
| 吸烟史 | 有=1,无=0 |
| 癌症家族史 | 有=1,无=0 |
| 结节类型 | 多发=1,单发=0 |
| 结节平均直径 | 实测值 |
| 结节体积 | 实测值 |
| 实性占比 | 实测值 |
| 结节部位 | 右肺上叶=1,右肺中叶=2,右肺下叶=3,左肺上叶=4,左肺下叶=5 |
| 恶性概率 | 高危=1,中危=0 |
| 表面征象 | 有=1,无=0 |
| 平均CT值 | 实测值 |
| 偏度 | 实测值 |
| 峰度 | 实测值 |
| 变量 | 单因素Cox比例风险回归分析 | 多因素Cox比例风险回归分析 | ||
|---|---|---|---|---|
| HR(95%CI) | P值 | HR(95%CI) | P值 | |
| 年龄 | 1.016(0.989,1.043) | 0.250 | — | — |
| 性别 | 0.759(0.380,1.516) | 0.434 | — | — |
| 吸烟史 | 1.863(0.949,3.659) | 0.071 | — | — |
| 癌症家族史 | 2.228(1.134,4.381) | 0.020 | — | — |
| 结节数目 | 1.088(0.530,2.233) | 0.817 | — | — |
| 结节平均直径 | 4.059(2.282,7.218) | <0.001 | 2.185(1.079,4.425) | 0.030 |
| 结节体积 | 1.001(1.001,1.002) | <0.001 | 1.001(1.000,1.001) | 0.022 |
| 实性占比 | 0.987(0.958,1.017) | 0.391 | — | — |
| 结节部位 | 1.047(0.817,1.341) | 0.717 | — | — |
| 恶性概率 | 2.559(1.245,5.260) | 0.011 | 2.232(1.036,4.806) | 0.040 |
| 表面征象 | 2.781(1.354,5.715) | 0.005 | 2.125(1.006,4.489) | 0.048 |
| 平均CT值 | 1.000(0.999,1.002) | 0.679 | — | — |
| 偏度 | 0.962(0.693,1.334) | 0.816 | — | — |
| 峰度 | 1.035(0.655,1.633) | 0.884 | — | — |
Table 3 Univariate and multivariate Cox proportional risk regression analyses of factors associated with the growth of solid pulmonary nodules
| 变量 | 单因素Cox比例风险回归分析 | 多因素Cox比例风险回归分析 | ||
|---|---|---|---|---|
| HR(95%CI) | P值 | HR(95%CI) | P值 | |
| 年龄 | 1.016(0.989,1.043) | 0.250 | — | — |
| 性别 | 0.759(0.380,1.516) | 0.434 | — | — |
| 吸烟史 | 1.863(0.949,3.659) | 0.071 | — | — |
| 癌症家族史 | 2.228(1.134,4.381) | 0.020 | — | — |
| 结节数目 | 1.088(0.530,2.233) | 0.817 | — | — |
| 结节平均直径 | 4.059(2.282,7.218) | <0.001 | 2.185(1.079,4.425) | 0.030 |
| 结节体积 | 1.001(1.001,1.002) | <0.001 | 1.001(1.000,1.001) | 0.022 |
| 实性占比 | 0.987(0.958,1.017) | 0.391 | — | — |
| 结节部位 | 1.047(0.817,1.341) | 0.717 | — | — |
| 恶性概率 | 2.559(1.245,5.260) | 0.011 | 2.232(1.036,4.806) | 0.040 |
| 表面征象 | 2.781(1.354,5.715) | 0.005 | 2.125(1.006,4.489) | 0.048 |
| 平均CT值 | 1.000(0.999,1.002) | 0.679 | — | — |
| 偏度 | 0.962(0.693,1.334) | 0.816 | — | — |
| 峰度 | 1.035(0.655,1.633) | 0.884 | — | — |
| 变量 | 单因素Cox比例风险回归分析 | 多因素Cox比例风险回归分析 | ||
|---|---|---|---|---|
| HR(95%CI) | P值 | HR(95%CI) | P值 | |
| 年龄 | 0.985(0.958,1.013) | 0.296 | — | — |
| 性别 | 1.023(0.536,1.949) | 0.946 | — | — |
| 吸烟史 | 1.877(0.999,3.526) | 0.050 | — | — |
| 癌症家族史 | 1.023(0.532,1.967) | 0.947 | — | — |
| 结节数目 | 0.862(0.452,1.645) | 0.653 | — | — |
| 结节平均直径 | 5.552(2.811,10.964) | <0.001 | 2.458(1.053,5.739) | 0.038 |
| 结节体积 | 1.001(1.000,1.001) | <0.001 | 1.001(1.000,1.002) | 0.010 |
| 实性占比 | 1.028(1.012,1.044) | 0.001 | 1.022(1.002,1.041) | 0.030 |
| 结节部位 | 0.990(0.804,1.218) | 0.922 | — | — |
| 恶性概率 | 2.813(1.422,5.562) | 0.003 | 2.386(1.174,4.850) | 0.016 |
| 表面征象 | 3.119(1.578,6.165) | 0.001 | 3.026(1.492,6.136) | 0.002 |
| 平均CT值 | 1.003(1.001,1.005) | 0.002 | 1.002(1.000,1.003) | 0.045 |
| 偏度 | 1.521(1.055,2.193) | 0.025 | — | — |
| 峰度 | 0.968(0.643,1.458) | 0.877 | — | — |
Table 4 Univariate and multivariate Cox proportional risk regression analyses of associated with the growth of ground-glass pulmonary nodules
| 变量 | 单因素Cox比例风险回归分析 | 多因素Cox比例风险回归分析 | ||
|---|---|---|---|---|
| HR(95%CI) | P值 | HR(95%CI) | P值 | |
| 年龄 | 0.985(0.958,1.013) | 0.296 | — | — |
| 性别 | 1.023(0.536,1.949) | 0.946 | — | — |
| 吸烟史 | 1.877(0.999,3.526) | 0.050 | — | — |
| 癌症家族史 | 1.023(0.532,1.967) | 0.947 | — | — |
| 结节数目 | 0.862(0.452,1.645) | 0.653 | — | — |
| 结节平均直径 | 5.552(2.811,10.964) | <0.001 | 2.458(1.053,5.739) | 0.038 |
| 结节体积 | 1.001(1.000,1.001) | <0.001 | 1.001(1.000,1.002) | 0.010 |
| 实性占比 | 1.028(1.012,1.044) | 0.001 | 1.022(1.002,1.041) | 0.030 |
| 结节部位 | 0.990(0.804,1.218) | 0.922 | — | — |
| 恶性概率 | 2.813(1.422,5.562) | 0.003 | 2.386(1.174,4.850) | 0.016 |
| 表面征象 | 3.119(1.578,6.165) | 0.001 | 3.026(1.492,6.136) | 0.002 |
| 平均CT值 | 1.003(1.001,1.005) | 0.002 | 1.002(1.000,1.003) | 0.045 |
| 偏度 | 1.521(1.055,2.193) | 0.025 | — | — |
| 峰度 | 0.968(0.643,1.458) | 0.877 | — | — |
| [1] |
|
| [2] |
杨锋,樊军,田周俊逸,等. 人群肺亚实性结节CT筛查及人工智能应用研究初探[J]. 中华胸心血管外科杂志,2020,36(3):145-150. DOI:10.3760/cma.j.cn112434-20191126-00420.
|
| [3] |
中华医学会呼吸病学分会肺癌学组,中国肺癌防治联盟专家组.肺结节诊治中国专家共识(2018年版)[J]. 中华结核和呼吸杂志,2018,41(10):763-771. DOI:10.3760/cma.j.issn.1001-0939.2018.10.004.
|
| [4] |
盛林丽.基于人工智能CT定量参数预测肺纯磨玻璃结节生长趋势的临床研究[D]. 昆明:昆明医科大学,2021.
|
| [5] |
李欣菱,王颖. 人工智能在肺结节检测与诊断中的应用及发展[J]. 新发传染病电子杂志,2019,4(3):185-189. DOI:10.19871/j.cnki.xfcrbzz.2019.03.014.
|
| [6] |
马景旭,陈欢,王红. 分析肺部影像人工智能诊断系统鉴别诊断肺结节性质[J]. 临床肺科杂志,2021,26(6):842-846.
|
| [7] |
刘娜,赵正凯,邹佳瑜,等. 基于人工智能的胸部CT肺结节检出及良恶性诊断效能评估[J]. CT理论与应用研究,2021,30(6):709-715. DOI:10.15953/j.1004-4140.2021.30.06.06.
|
| [8] |
曹孟昆,姜杰,朱晓雷,等. 人工智能肺部结节辅助诊疗系统预测肺结节的良恶性及浸润情况[J]. 中国胸心血管外科临床杂志,2021,28(3):283-287.
|
| [9] |
尹泚,毛文杰,李斌,等. 人工智能系统在肺结节检出及良恶性鉴别中的应用研究[J]. 中华胸心血管外科杂志,2020,36(9):553-556. DOI:10.3760/cma.j.cn112434-20200817-00375.
|
| [10] |
|
| [11] |
中华医学会放射学分会心胸学组. 低剂量螺旋CT肺癌筛查专家共识[J]. 中华放射学杂志,2015,9(5):328-335.
|
| [12] |
|
| [13] |
|
| [14] |
|
| [15] |
李甜,李晓东,刘敬禹. 人工智能辅助诊断肺结节的临床价值研究[J]. 中国全科医学,2020,23(7):828-831,836. DOI:10.12114/j.issn.1007-9572.2020.00.052.
|
| [16] |
|
| [17] |
|
| [18] |
范卫杰,张冬. 影像组学及深度学习在肺结节良恶性鉴别诊断中的新理念[J]. 中华肺部疾病杂志:电子版,2021,14(5):549-553.
|
| [19] |
张晓菊.《肺结节诊治中国专家共识(2018版)》解读[J]. 中华实用诊断与治疗杂志,2019,33(1):1-3.
|
| [20] |
蔡雅倩,张正华,韩丹,等. AI对肺磨玻璃结节筛查及定性的临床应用研究[J]. 放射学实践,2019,34(9):958-962. DOI:10.13609/j.cnki.1000-0313.2019.09.005.
|
| [21] |
|
| [22] |
张正华,周小君,韩丹,等. 基于AI对磨玻璃密度早期肺癌浸润相关因素Logistic回归分析[J]. 临床放射学杂志,2020,39(10):2120-2123. DOI:10.13437/j.cnki.jcr.2020.10.045.
|
| [23] | |
| [24] |
|
| [25] |
|
| [26] |
张世佳,赵静,任胜祥,等. 生物标记物应用于肺癌早期诊断和筛查研究进展[J]. 中华健康管理学杂志,2017,11(4):383-387. DOI:10.3760/cma.j.issn.1674-0815.2017.04.018.
|
| [1] | AN Yanhong, WANG Shidong, LI Xiaoran, GUO Jiayang, WANG Zhe, SHA Peilin, MENG Yijun, LI Xiaoxuan, SHI Xue, YU Zexing, XIAO Yonghua. Study on Risk Factors and Nomogram Prediction Model for Diabetic Kidney Disease: Based on Contrast-enhanced Ultrasound Technology [J]. Chinese General Practice, 2026, 29(21): 2995-3003. |
| [2] | SONG Zhenzhen, CHEN Yang, WANG Jiwen, LIU Huishan, SHEN Simeng, SUN Ying, CHEN Xing. Study of Maternal Risk Factors Associated with Neonatal Asphyxia in Late Preterm and Term Infants [J]. Chinese General Practice, 2026, 29(20): 2874-2878. |
| [3] | YANG Xiaofeng, LI Xianwen, WU Yanfeng, ZHANG Qian, CHEN Juan, ZHAO Fengjiao. Association of Serum Vascular Endothelial Cadherin Levels with the Risk of Post-stroke Cognitive Impairment in Patients with Acute Ischemic Stroke [J]. Chinese General Practice, 2026, 29(20): 2867-2873. |
| [4] | ZHAO Huili, LU Lina, ZHUO Ya, WANG Xin. Clinical Characteristics and Risk Factors for Recurrence of Cryptogenic Organizing Pneumonia [J]. Chinese General Practice, 2026, 29(19): 2648-2655. |
| [5] | HU Min, LYU Xiangdong. Accuracy of Artificial Intelligence in Remote Electrocardiography Diagnosis [J]. Chinese General Practice, 2026, 29(18): 2498-2503. |
| [6] | ZHEN Rui, GU Xufang, GAO Shengwei, ZHANG Bowen, REN Zhenjuan, YANG Ruixuan. Burden of Cardiovascular Diseases Attributable to Metabolic Risk Factors in China 1990—2021 and Projected Trends from 2022 to 2035 [J]. Chinese General Practice, 2026, 29(15): 2077-2083. |
| [7] | XU Qinghong, WANG Jing, HUANG Yuan, ZHU Ci, CAO Wenbing, LI Ying. A Validation Study on Measuring Colorectal Polyp Size Using a Deep Learning-based Real-time Colorectal Polyp Measurement System [J]. Chinese General Practice, 2026, 29(14): 1873-1877. |
| [8] | ZHANG Hanyu, GU Jie, LIN Yingnan, HUANG Yanyan. Discussion on the Application of AI-based Simulated-scenario Standardized Patients in the Standardized Training Teaching of General Practice Resident Physicians [J]. Chinese General Practice, 2026, 29(13): 1726-1731. |
| [9] | YANG Lei, GUAN Hua. Application Progress of Generative Artificial Intelligence in Weight Management [J]. Chinese General Practice, 2026, 29(12): 1533-1540. |
| [10] | HU Jiaqi, LI Duan, FANG Hao, FAN Xingying, DU Wei, ZHOU Hanni. Study on Predictive Model of Non-genetic Risk Factors for Hyperuricemia in a Physical Examination Cohort [J]. Chinese General Practice, 2026, 29(10): 1324-1333. |
| [11] | Expert Panel of the Consensus on Artificial Intelligence Empowering Healthcare Services. Artificial Intelligence Empowering Healthcare Services: Expert Consensus from the Mangrove Health Conference in 2025 [J]. Chinese General Practice, 2026, 29(07): 817-822. |
| [12] | WANG Lina, LEI Jingshu, LI Kuibao, WANG Ruiying, LI Xinmiao, WANG Fangfang, GUO Xiaorong, NIU Ruihao, ZHAO Wei, ZHOU Fangfang, ZHAO Jingjing, LEE CHONGYOU. Review on Inflammatory Response in Patients with Acute Myocardial Infarction [J]. Chinese General Practice, 2026, 29(06): 790-801. |
| [13] | YAO Wenjing, WANG Cuifeng, GAO Jinliang, REN Meiying, JING Xuefen, FU Yuhua. Autophagy Related Proteins Beclin-1 and LC3-ⅡExpression in Lung Cancer Metaststic Pleural Effusion [J]. Chinese General Practice, 2026, 29(05): 623-630. |
| [14] | LEI Yingying, ZHENG Siying, WANG Wenxin, JIANG Hong. Prevalence Trend and Prediction of Hypertensive Heart Disease in the World and China from 1990 to 2021 [J]. Chinese General Practice, 2026, 29(05): 641-648. |
| [15] | LI Xi, LIU Jue. Artificial Intelligence Empowers Primary Healthcare Services: Progress and Challenges [J]. Chinese General Practice, 2026, 29(04): 436-443. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||